Last reviewed · How we verify
NCT03697213
The Surprise Study
trial testing Online study in Palliative Care in 250 participants. Completed in 1 March 2020.
1 March 2020
Quick facts
| Lead sponsor | University College, London |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 25 March 2019 |
| Primary completion | 1 March 2020 |
| Estimated completion | 1 March 2020 |
| Sites | 6 locations across Italy, Netherlands, Belgium, United Kingdom, Germany, Switzerland |
Drugs / interventions tested
- Online study
Conditions studied
- Palliative Care — all drugs for Palliative Care →
- Terminal Illness — all drugs for Terminal Illness →
Sponsor
University College, London
Who can join
18 and older, any sex, with Palliative Care or Terminal Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the use of the Surprise Question \[SQ\] (would you be surprised if this patient were to die in the next 12 months?) in routine practice. In particular, the study will investigate the consistency of the responses to the SQ and the relationship with the subsequent course of action decided upon.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
An online international comparison of palliative care identification in primary care using the Surprise Question.
White N, Oostendorp LJ, Vickerstaff V, Gerlach C, et al · · 2022 · cited 6× · PMID 34596445 · DOI 10.1177/02692163211048340 -
An online international comparison of thresholds for triggering a negative response to the "Surprise Question": a study protocol.
White N, Oostendorp L, Vickerstaff V, Gerlach C, et al · · 2019 · cited 5× · PMID 30979361 · DOI 10.1186/s12904-019-0413-x
Verify or expand the search:
- PubMed search for NCT03697213
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Palliative Care
Currently open trials in the same condition.
- NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting
- NCT07469761 — MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care · NA · recruiting
- NCT06588556 — Improving Needs Among Older Adults · NA · recruiting
- NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
- NCT06771999 — Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Phar · NA · recruiting
Other University College, London trials
Trials by the same sponsor.
- NCT07386652 — Intensive Comprehensive Aphasia Programme for People With Post-Stroke Aphasia · NA · not yet recruiting
- NCT06924086 — The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial · NA · recruiting
- NCT07386678 — Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment · not yet recruiting
- NCT07414940 — ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium · Phase 1, PHASE2 · not yet recruiting
- NCT07214454 — TCDS for the Treatment of Chronic Migraine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03697213 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University College, London
- Last refreshed: 27 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03697213.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing